Abstract: The invention provides methods and materials for antisense oligonucleotide therapy against active pathogenic infection by drug resistant or drug sensitive pathogens, including Plasmodium falciparum.
Type:
Grant
Filed:
January 7, 1994
Date of Patent:
April 1, 1997
Assignee:
Worcester Foundation for Biomedical Research, Inc.